Ljungberg B, Roos G, Stenling R
Department of Urology, University of Umeå, Sweden.
Semin Surg Oncol. 1988;4(3):165-8. doi: 10.1002/ssu.2980040305.
Tumor DNA content was analysed in 26 patients with metastatic renal cell carcinoma. The primary tumors were homogenously diploid in ten patients (38%). In 16 patients (62%) an aneuploid DNA content was found in at least one of eight tumor samples analyzed. Patients with diploid tumors survived significantly longer (P less than 0.001) than patients with aneuploid primary tumors (median 32.5 and 6 months, respectively). The DNA content of the metastases seems to give additional prognostic information. The results indicate that DNA content is a useful prognostic predictor in renal cell carcinoma. Patients with homogenously diploid tumors might be treated aggressively with nephrectomy and excision of apparent metastases, particularly solitary, since these patients seem to have a chance for prolonged survival time. Aneuploidy in metastases, solitary and multiple, indicates that nephrectomy is not meaningful.
对26例转移性肾细胞癌患者的肿瘤DNA含量进行了分析。10例患者(38%)的原发性肿瘤为均一的二倍体。在16例患者(62%)中,在所分析的8个肿瘤样本中至少有一个发现非整倍体DNA含量。二倍体肿瘤患者的生存期明显长于非整倍体原发性肿瘤患者(P<0.001)(中位生存期分别为32.5个月和6个月)。转移灶的DNA含量似乎能提供额外的预后信息。结果表明,DNA含量是肾细胞癌有用的预后预测指标。均一的二倍体肿瘤患者可能适合积极进行肾切除术和切除明显的转移灶,尤其是孤立性转移灶,因为这些患者似乎有延长生存时间的机会。转移灶(无论孤立性还是多发性)出现非整倍体表明肾切除术没有意义。